Neogen Chemicals (NEOGEN) Q4 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 24/25 earnings summary
8 Jul, 2026Executive summary
Achieved 13% consolidated revenue growth in FY25, reaching ₹778 crore, and 24% EBITDA growth to ₹136 crore, despite a fire at the Dahej facility and weak global pricing.
PAT for FY25 was ₹34.8 crore, down 2% due to an exceptional loss of ₹14 crore from the fire; profitability would have been higher excluding this charge.
Demonstrated operational resilience by shifting production to other sites, beginning reconstruction at Dahej, and focusing on high-demand segments like semiconductors, flavors, fragrances, and pharma.
Initiated strategic expansion in lithium and battery materials, including a JV with Morita Chemical Industries, capacity additions in lithium electrolyte salts and additives, and incorporation of a new subsidiary.
Audited standalone and consolidated financial results for Q4 and FY25 approved, with unmodified audit opinions; final dividend of Re. 1 per share recommended.
Financial highlights
FY25 consolidated revenue: ₹777.6 crore (up 13% YoY); standalone revenue: ₹773.7 crore (up 10%).
FY25 consolidated EBITDA: ₹136.3 crore (+24%), margin at 17.5% (+160 bps YoY); standalone EBITDA: ₹105.51 crore.
FY25 consolidated PAT: ₹34.8 crore, down 2% YoY due to exceptional items; standalone PAT: ₹48.41 crore.
Q4 FY25 consolidated revenue: ₹202.8 crore; EBITDA: ₹36.4 crore; PAT: ₹2.4 crore, impacted by the fire.
Standalone EPS for FY25: ₹18.35; consolidated EPS: ₹13.20.
Outlook and guidance
FY26 revenue guidance revised to ₹750–850 crore due to the Dahej fire, with plant reconstruction targeted for Q4 FY26.
Battery chemicals revenue for FY26 expected closer to ₹300 crore, with a target of over ₹1,000 crore in FY27, subject to market ramp-up and customer approvals.
Greenfield battery materials facility using MUIS technology on track for commissioning by March 2026.
Company continues to focus on specialty chemicals as a single operating segment, with expansion into lithium-ion battery materials.
Latest events from Neogen Chemicals
- Q1 FY27 saw 34% revenue and 67% PAT growth, with Dahej plant recovery and full fund utilization.NEOGEN
Q1 26/27 - Q4 FY 2026 delivered 22% YoY revenue growth, with battery materials and insurance recovery supporting expansion.NEOGEN
Q4 25/26 - Q3 FY26 revenue up 9% YoY; battery chemical expansion and equity fundraising advance.NEOGEN
Q3 25/26 - Revenue up 8% in Q2 FY26; PAT fell on higher costs, battery ramp-up delayed, NCDs issued.NEOGEN
Q2 25/26 - Q1 FY26 delivered resilient growth, CapEx progress, and leadership transition amid recovery.NEOGEN
Q1 25/26 - Q2 FY25 delivered 20% revenue and 38% PAT growth, with robust expansion and global focus.NEOGEN
Q2 24/25 - Q1 FY25 profit and revenue rose 9% and 18%, with battery chemical expansion and board changes.NEOGEN
Q1 24/25 - Q3 FY25 revenue and PAT surged YoY, led by BuLi Chem integration and battery materials growth.NEOGEN
Q3 24/25